| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1059-1069, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
PJ Marie, C de Pollak, P Chanson and A Lomri
INSERM U349, Paris, France.
We studied the osteoblastic abnormalities resulting from activating mutation of the Gs alpha gene in two patients with McCune-Albright syndrome and one patient with monostotic fibrous dysplasia. Histomorphometric analysis of dysplastic lesions showed a low number of differentiated osteoblasts along the bone surface and numerous immature alkaline phosphatase-positive mesenchymal cells actively depositing a woven bone matrix. Osteoblastic cells isolated from dysplastic bone lesions expressed a missense mutation in the Gs alpha gene in position 201 and showed increased intracellular basal cyclic adenosine 3',5'- monophosphate levels compared with normal cells isolated from a noninvolved area in the same patient. Cell proliferation evaluated by DNA synthesis was two-fold to threefold greater in osteoblastic cells expressing the mutation compared with normal cells from the same patient and was greater in cells isolated from more severe than less severe fibrotic lesions. In contrast, the synthesis of osteocalcin, a marker of mature osteoblasts, was lower in osteoblastic cells expressing the Gs alpha mutation compared with normal cells from the same patient and was lower in cells isolated from severe compared with less severe fibrotic lesions, indicating that the increased growth in mutated osteoblastic cells was associated with reduced cell differentiation. The results show that activating mutation of Gs alpha in osteoblastic cells leads to constitutive activation of adenylate cyclase, increased cell proliferation, and inappropriate cell differentiation, resulting in overproduction of a disorganized fibrotic bone matrix in polyostotic and monostotic fibrous dysplasia.
This article has been cited by other articles:
 |
|
 |
|
  M. R. DiCaprio and W. F. Enneking Fibrous Dysplasia. Pathophysiology, Evaluation, and Treatment J. Bone Joint Surg. Am., August 1, 2005; 87(8): 1848 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Plotkin, F. Rauch, L. Zeitlin, C. Munns, R. Travers, and F. H. Glorieux Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4569 - 4575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lee, E. FitzGibbon, J. A. Butman, C. R. Dufresne, H. Kushner, S. Wientroub, P. G. Robey, and M. T. Collins Normal Vision despite Narrowing of the Optic Canal in Fibrous Dysplasia N. Engl. J. Med., November 21, 2002; 347(21): 1670 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. WEINSTEIN, M. CHEN, and J. LIU Gs{alpha} Mutations and Imprinting Defects in Human Disease Ann. N.Y. Acad. Sci., June 1, 2002; 968(1): 173 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sakamoto, Y. Oda, Y. Iwamoto, and M. Tsuneyoshi A Comparative Study of Fibrous Dysplasia and Osteofibrous Dysplasia with Regard to GS{alpha} Mutation at the Arg201 Codon: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Analysis of Paraffin-Embedded Tissues J. Mol. Diagn., May 1, 2000; 2(2): 67 - 72. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. KITOH, Y. YAMADA, and H. NOGAMI Different genotype of periosteal and endosteal cells of a patient with polyostotic fibrous dysplasia J. Med. Genet., September 1, 1999; 36(9): 724 - 725. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
